comparemela.com

Frazier Life Sciences Management L.P. grew its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,764,232 shares of the company’s stock after buying an additional 80,000 shares during […]

Related Keywords

Larry Todd Edwards , Cantor Fitzgerald , Arcutis Biotherapeutics , Patrick Burnett , Capital Management , Ghisallo Capital Management , Needham Company , Nasdaq , Arcutis Biotherapeutics Inc , Securities Exchange Commission , Goldman Sachs Group , Venture Partners Investment Advisor , Frazier Life Sciences Management , Free Report , Get Free Report , Exchange Commission , Todd Edwards , Visit Holdingschannel ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.